Literature DB >> 26390423

Thirty-Day Readmission Predicts 1-Year Mortality in Acute Pancreatitis.

Peter J W Lee1, Amit Bhatt, Rocio Lopez, Tyler Stevens.   

Abstract

OBJECTIVES: There is limited knowledge of the prognostic indicators after hospital discharge after acute pancreatitis (AP). The aim was to determine risk factors for mortality after discharge in patients admitted with AP.
METHODS: A retrospective cohort study was conducted, including consecutive patients with AP admitted to the Cleveland Clinic between 2007 and 2011. Clinical data, mortality status, and the date of death were collected. Univariable and multivariable Cox regression was performed to determine variables significantly associated with mortality within a year of discharge.
RESULTS: Three hundred thirty-one patients were included in the study, current to July 2012. After a mean follow-up of 20 months, 41 subjects (12.4%) died after discharge from the hospital. Thirty-three (10.0%) died within a year after discharge. In univariable analyses, higher Charlson Comorbidity Index, blood urea nitrogen > 20 on admission, higher Bedside Index of Severity in Acute Pancreatitis scores, longer length of stay, and readmission within 30 days were associated with a higher hazard of mortality. In the multivariable analysis, subjects who were readmitted within 30 days had a 4.5 times higher hazard of dying within a year than those who were not readmitted (hazard ratio, 4.5; 95% confidence interval, 2.2-9.1).
CONCLUSION: A higher Charlson Comorbidity Index, early readmission, and longer hospitalization predict a higher 1-year mortality after AP.

Entities:  

Mesh:

Year:  2016        PMID: 26390423     DOI: 10.1097/MPA.0000000000000463

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Factors Associated With Length of Stay and 30-Day Revisits in Pediatric Acute Pancreatitis.

Authors:  Anna C Gay; Nicolas B Barreto; Sheree M Schrager; Christopher J Russell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-08       Impact factor: 2.839

2.  Cholecystectomy During Index Admission for Acute Biliary Pancreatitis Lowers 30-Day Readmission Rates.

Authors:  Somashekar G Krishna; Andrew J Kruger; Nishi Patel; Alice Hinton; Dhiraj Yadav; Darwin L Conwell
Journal:  Pancreas       Date:  2018-09       Impact factor: 3.327

3.  Opiate Prescriptions at Discharge Are Not Associated with Early Readmissions in Acute Pancreatitis.

Authors:  Allison L Yang; David X Jin; Meghan Rudder; Shadeah Suleiman; Peter A Banks; Julia McNabb-Baltar
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

4.  The Pancreatitis Activity Scoring System predicts clinical outcomes in acute pancreatitis: findings from a prospective cohort study.

Authors:  James Buxbaum; Michael Quezada; Bradford Chong; Nikhil Gupta; Chung Yao Yu; Christianne Lane; Ben Da; Kenneth Leung; Ira Shulman; Stephen Pandol; Bechien Wu
Journal:  Am J Gastroenterol       Date:  2018-03-15       Impact factor: 10.864

5.  Thirty-Day Readmission Among Patients with Alcoholic Acute Pancreatitis.

Authors:  Pedro Palacios Argueta; Miguel Salazar; Ishaan Vohra; Juan E Corral; Frank J Lukens; John J Vargo; Prabhleen Chahal; C Roberto Simons-Linares
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

Review 6.  Recent advances in understanding and managing acute pancreatitis.

Authors:  Amar Mandalia; Erik-Jan Wamsteker; Matthew J DiMagno
Journal:  F1000Res       Date:  2018-06-28

7.  Extra-pancreatic complications, especially hemodialysis predict mortality and length of stay, in ICU patients admitted with acute pancreatitis.

Authors:  Darshan Kothari; Maarten R Struyvenberg; Michael C Perillo; Ghideon Ezaz; Steven D Freedman; Sunil G Sheth
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-03-03

8.  Immune Dysfunction is Associated with Readmission in Survivors of Sepsis Following Infected Pancreatic Necrosis.

Authors:  Jiangtao Yin; Wenjian Mao; Xiaojia Xiao; Xianqiang Yu; Baiqiang Li; Faxi Chen; Jiajia Lin; Jing Zhou; Jing Zhou; Zhihui Tong; Lu Ke; Weiqin Li
Journal:  J Inflamm Res       Date:  2021-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.